Valley Brook Capital Group’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.26M Buy
2,600
+275
+12% +$73K 0.71% 40
2026
Q1
$255K Buy
2,325
+75
+3% +$10.7K 0.17% 98
2025
Q4
$374K Buy
2,250
+780
+53% +$130K 0.25% 80
2025
Q3
$288K Buy
+1,470
New +$242K 0.19% 92

Other funds holding ALAB

Valley Brook Capital Group's ALAB Position: Q2 2026 in Review

Valley Brook Capital Group increased its Astera Labs (ALAB) stake by 12% in Q2 2026, buying an estimated $73K and bringing the position to 2,600 shares worth $1.26M. The position accounts for 0.71% of the portfolio, ranked #40.

Valley Brook Capital Group first reported a position in ALAB in Q3 2025 and has held it in 4 quarters since. 991 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Valley Brook Capital Group held 2,600 shares of Astera Labs worth $1.26M as of Q2 2026.
  • Valley Brook Capital Group bought 275 Astera Labs shares in Q2 2026, an estimated $73K.
  • Astera Labs made up 0.71% of Valley Brook Capital Group's portfolio in Q2 2026, its #40 holding.
  • Valley Brook Capital Group first reported a position in Astera Labs in Q3 2025 and has held it in 4 quarters since.
  • 991 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Valley Brook Capital Group's 13F filing for Q2 2026, filed 27 Jul 2026.